To study the effect of Panchakarma Somvalkal kashay siddha basti in Madhumeha

Phase 3

Completed

• Conditions: Health Condition 1: E119- Type 2 diabetes mellitus without complications

• Registration Number: CTRI/2019/02/017458
• Lead Sponsor: Dr Nakul Khode

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-12-27
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 31

Inclusion Criteria

Patients with symptoms of Prameha as per Ayurvedic classics and Type 2 diabetes mellitus as per modern medicine

Age group between 30 to 60 years

HbA1c value will 6.5 percentage or above

Patients taking Biguanides group anti-diabetic drugs

Fasting blood sugar level within 150 mgdl and Post prandial blood sugar within 250 mgdl

Basti Arha

Exclusion Criteria

HbA1c values will less than 6.5 percentage

Patients taking other than Biguanides group anti diabetic drugs

Patients of Insulin dependent diabetes mellitus

Diabetes due to Endocrinopathies for eg Pheochromocytoma Acromegaly Cushing syndrome

Drugs or chemical induced diabetes mellitus eg Glucocorticoids thyroid hormone Thiazide Phenytoin etc

Patients with other systemic complication like cardiovascular nephropathic diseases etc

Basti Anarha

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study the efficacy of BastiTimepoint: 90 days

Secondary Outcome Measures

Name	Time	Method
To study the Quality of life improvement in diabetic patientTimepoint: 90 days